Conserved structure and function in the granulysin and NK-lysin peptide family.
Granulysin and NK-lysin are homologous bactericidal proteins with a moderate residue identity (35%), both of which have antimycobacterial activity. Short loop peptides derived from the antimycobacterial domains of granulysin, NK-lysin, and a putative chicken NK-lysin were examined and shown to have comparable antimycobacterial but variable Escherichia coli activities. The known structure of the NK-lysin loop peptide was used to predict the structure of the equivalent peptides of granulysin and chicken NK-lysin by homology modeling. The last two adopted a secondary structure almost identical to that of NK-lysin. All three peptides form very similar three-dimensional (3-D) architectures in which the important basic residues assume the same positions in space. The basic residues in granulysin are arginine, while those in NK-lysin and chicken NK-lysin are a mixture of arginine and lysine. We altered the ratio of arginine to lysine in the granulysin fragment to examine the importance of basic residues for antimycobacterial activity. The alteration of the amino acids reduced the activity against E. coli to a larger extent than that against Mycobacterium smegmatis. In granulysin, the arginines in the loop structure are not crucial for antimycobacterial activity but are important for cytotoxicity. We suggest that the antibacterial domains of the related proteins granulysin, NK-lysin, and chicken NK-lysin have conserved their 3-D structure and their function against mycobacteria.
Linde
Charlotte M A
CM
Microbiology and Tumor Biology Center, Karolinska Institutet, Stockholm, Sweden. charlotte.linde@mtc.ki.se
Grundström
Susanna
S
Nordling
Erik
E
Refai
Essam
E
Brennan
Patrick J
PJ
Andersson
Mats
M
D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D000818:Animals; D000890:Anti-Infective Agents / Q000737:chemistry* / Q000494:pharmacology; D000945:Antigens, Differentiation, T-Lymphocyte / Q000737:chemistry* / Q000494:pharmacology; D001120:Arginine / Q000235:genetics; D002478:Cells, Cultured; D017124:Conserved Sequence; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D008239:Lysine / Q000235:genetics; D008969:Molecular Sequence Data; D019910:Mycobacterium marinum / Q000187:drug effects; D020102:Mycobacterium smegmatis / Q000187:drug effects; D010455:Peptides / Q000737:chemistry* / Q000494:pharmacology; D011487:Protein Conformation; D011510:Proteolipids / Q000737:chemistry* / Q000494:pharmacology
D000890:Anti-Infective Agents; D000945:Antigens, Differentiation, T-Lymphocyte; C075005:GNLY protein, human; C093238:NK-lysin; D010455:Peptides; D011510:Proteolipids; D001120:Arginine; D008239:Lysine